Data for: A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Name: Data for: A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
Creator: Kendra Sweet
Published: 2018-10-16T11:36:39.081Z
Keywords: Oncology

Sweet, Kendra

doi:10.17632/6p55yyz5hn.1

Data for: A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Published: 16 October 2018| Version 1 | DOI: 10.17632/6p55yyz5hn.1

Contributor:

Kendra Sweet

Description

Protocol: A phase I study of combination with nilotinib and ruxolitinib in CML patients with evidence of molecular disease

Data for: A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Description

Files

Categories

Licence